MedPath

The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery

Not Applicable
Completed
Conditions
Surgical Site Infection
Interventions
Other: Wound dressing removal.
Registration Number
NCT02902419
Lead Sponsor
Albany Medical College
Brief Summary

A randomized controlled trial measuring surgical site infection rate as a function of timing of wound dressing removal.

Detailed Description

A randomized controlled trial with a sample size of 602 patients to study the effect of timing of wound dressing removal on the surgical site infection rate. 300 patients were randomized to a group that had the wound dressing removed between 12-30 hours postoperatively. 302 patients were randomized to a group that had the wound dressing removal between 30-48 hours postoperatively. Statistical analyses were performed to determine if the timing of dressing removal had statistical significance on the surgical site infection rate, the primary outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
602
Inclusion Criteria
  • patients ages 18-50 years;
  • medically competent (no proxies or prisoners); and
  • multifetal and singleton gestations from 23 0/7 weeks to 42 0/7 weeks gestational age.
Exclusion Criteria
  • Inability to obtain informed consent;
  • fetal death;
  • immunocompromised patients; patients taking immuno-suppressants; history of documented surgical site infection; or patients requiring reoperation within the 6 week postoperative period for indications other than wound dehiscence/debridement/infection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Wound dressing removal.Wound dressing removal was performed between 30-48 hours postoperatively.
1Wound dressing removal.Wound dressing removal was performed between 12-30 hours postoperatively.
Primary Outcome Measures
NameTimeMethod
Surgical Site infection Rate6 weeks postoperatively

Cellulitis, purulent drainage, abscess or wound requiring drainage, debridement, and antibiotics associated with a clinical diagnosis of infection. Any disruption of fascia or subcutaneous skin.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

St. Peter's Hospital

🇺🇸

Albany, New York, United States

Bellevue Women's Center

🇺🇸

Niskayuna, New York, United States

© Copyright 2025. All Rights Reserved by MedPath